Results 81 to 90 of about 27,778 (225)
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Transient liver steatosis is rarely described. A fast development of liver steatosis leading to acute liver failure (ALF) is, to our knowledge, rarely observed. It is so far observed and published in acute fatty liver of pregnancy, and in a few cases of ALF. However, it is observed in elective surgery for pancreaticoduodenectomy and some cases
Anders Benjamin Kildal +7 more
wiley +1 more source
Journal of Translational Medicine, 2012 Background Blood biomarkers are needed to monitor anti-angiogenic treatments for cancer. The association of blood levels of microRNAs (miRs) implicated in angiogenesis with circulating endothelial cells (CEC) and with angiogenic proteins was examined in ...
Triozzi Pierre L +5 more
doaj +1 more source
, 2014 AIM: To investigate the predictability of interleukin-28B single nucleotide polymorphism rs12979860 with respect to sustained virological response (SVR) in chronically hepatitis C virus (HCV) genotype-1 patients treated with a protease-inhibitor and ...
Amanzada, Ahmad +3 more
core +1 more source
MedComm, Volume 7, Issue 2, February 2026.Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Multisystem sarcoidosis in a patient on interferon-α therapy for chronic hepatitis C
Journal of Global Infectious Diseases, 2012 Sarcoidosis is a chronic multisystemic granulomatous disease that is triggered by an autoimmune process. Nowadays, this pathology represents a well-recognized but uncommon complication for antiviral treatment in hepatitis C virus (HCV) infection. Herein,
Bouchra Oudghiri +4 more
doaj +1 more source
Acta Gastroenterológica Latinoamericana, 2009 Introducción. El tratamiento recomendado para los pacientes con hepatitis B crónica HBeAg positivo es PEG interferón alfa 2a durante 48 semanas. No hay suficientes datos que avalen mejor respuesta con 48 semanas de tratamiento versus 24 semanas.
Joaquín Solari +9 more
doaj
Brazilian Journal of Infectious DiseasesPeginterferon alfa plus ribavirin is currently the treatment of choice for chronic hepatitis C. Peginterferon alfa-2a (40KD) plus ribavirin has given an overall sustained virological response of 18% in F3/F4 previous nonresponder US patients.
E. Parise +16 more
doaj +1 more source
Annals of Hepatology, 2012 Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients ...
Mario G. Pessôa +12 more
doaj +1 more source
Креативная хирургия и онкология, 2019 Introduction. Despite the fact that the combined use of bevacizumab and interferon α -2A has been studied extensively and proved to be safe, there will always remain a group of patients for whom continuing the long-term drug treatment after a radical ...
K. Sh. Gantsev, A. A. Khmelevskiy
doaj +1 more source
Metastatic renal cell carcinoma presenting as a paranasal sinus mass: the importance of differential diagnosis [PDF]
, 2017 Metastases in the paranasal sinuses are rare; renal cell carcinoma is the most common cancer that metastasizes to this region. We present the case of a patient with a 4-month history of a rapidly growing mass of the nasal pyramid following a nasal trauma,
ALTISSIMI, Giancarlo +3 more
core +4 more sources